0001853373-22-000001.txt : 20220111 0001853373-22-000001.hdr.sgml : 20220111 20220111140010 ACCESSION NUMBER: 0001853373-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 EFFECTIVENESS DATE: 20220111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kestrel Therapeutics Inc. CENTRAL INDEX KEY: 0001853373 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428830 FILM NUMBER: 22523523 BUSINESS ADDRESS: STREET 1: 102 SEARS ROAD CITY: WAYLAND STATE: MA ZIP: 01778 BUSINESS PHONE: 617-460-3772 MAIL ADDRESS: STREET 1: 102 SEARS ROAD CITY: WAYLAND STATE: MA ZIP: 01778 D 1 primary_doc.xml X0708 D LIVE 0001853373 Kestrel Therapeutics Inc. 102 SEARS ROAD WAYLAND MA MASSACHUSETTS 01778 617-460-3772 DELAWARE None None Corporation true 2020 Frank G. Haluska c/o Kestrel Therapeutics Inc. 102 Sears Road Wayland MA MASSACHUSETTS 01778 Executive Officer Director Denis Patrick c/o Kestrel Therapeutics Inc. 102 Sears Road Wayland MA MASSACHUSETTS 01778 Director Omar Khalil c/o Kestrel Therapeutics Inc. 102 Sears Road Wayland MA MASSACHUSETTS 01778 Director Andrew Phillips c/o Kestrel Therapeutics Inc. 102 Sears Road Wayland MA MASSACHUSETTS 01778 Director Biotechnology Decline to Disclose 06b false 2021-12-28 true true false 0 40000000 7500000 32500000 Remaining amounts subject to completion of milestones. false 6 0 0 0 false Kestrel Therapeutics Inc. Frank G. Haluska Frank G. Haluska President and Chief Executive Officer 2022-01-11